The share price of Metlen has seen a notable recovery, rising by at least +5.5% over the last two days after hitting a low of 35 euros. This resurgence marks the stock's return to the 37 euro level for the first time since February 6. The improvement in Metlen's market performance is attributed to the positive sentiments expressed by credit rating agencies S&P and Fitch about the company’s economic prospects for 2026, despite a recent profit warning.

This rally in stock performance reflects broader market reactions to analysts' evaluations, suggesting confidence in Metlen's ability to navigate predicted market challenges. The backing from S&P and Fitch not only reassures investors but also bolsters the overall sentiment towards the company. Such ratings signal to the market that Metlen could be on a path to recovery and growth, which is crucial in times of uncertainty.

Despite this positive news, it is essential to note that the article cautions against treating this as a buying recommendation. Investors need to conduct thorough research and consider their personal investment strategies while keeping an eye on market dynamics and company performance before making any decisions.